Literature DB >> 1428996

Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells.

M B Teunissen1.   

Abstract

Epidermal Langerhans cells (LC) are Birbeck granule-containing bone-marrow-derived cells, which are located mainly in the suprabasal layer of the epidermis. They can be readily identified by their strong expression of CD1a and MHC class II molecules. In addition to these 'classical' properties, an extensive phenotypic profile of normal human LC, summarized in this review, is now available. The powerful capacity of LC to activate T lymphocytes is clearly documented and, to date, LC are recognized as the prominent antigen-presenting cells of the skin immune system. They are generally believed to pick up antigens encountered in the epidermis and to migrate subsequently from the epidermis to the skin-draining lymph nodes. Upon arrival in the paracortex of lymph nodes, the antigen-laden LC transform into interdigitating cells and they present antigen to naive T lymphocytes in a MHC class II-restricted fashion; this results in the generation of antigen-specific immune responses. It has also been demonstrated that transformation of LC into interdigitating cells occurs when LC are cultured in vitro. Both in vivo and in vitro studies have indicated that properties of LC, such as phenotype, morphology and the stimulatory potential to activate T lymphocytes, are dependent on the local microenvironment in which the LC reside. The essential role of LC in the induction of contact allergic skin reactions and skin transplant rejection is well established.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1428996     DOI: 10.1007/bf01460823

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  178 in total

Review 1.  The Langerhans cell.

Authors:  S M Breathnach
Journal:  Br J Dermatol       Date:  1988-10       Impact factor: 9.302

2.  The skin immune system Its cellular constituents and their interactions.

Authors:  J D Bos; M L Kapsenberg
Journal:  Immunol Today       Date:  1986 Jul-Aug

3.  Ultrastructural and phenotypic changes in Langerhans cells induced in vitro by contact allergens.

Authors:  C A Picut; C S Lee; R M Lewis
Journal:  Br J Dermatol       Date:  1987-06       Impact factor: 9.302

Review 4.  The langerhans cell.

Authors:  K Wolff
Journal:  Curr Probl Dermatol       Date:  1972

Review 5.  Origin and function of epidermal Langerhans cells.

Authors:  G Stingl; K Tamaki; S I Katz
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

6.  Langerhans cells as primary target cells for HIV infection.

Authors:  L R Braathen; G Ramirez; R O Kunze; H Gelderblom
Journal:  Lancet       Date:  1987-11-07       Impact factor: 79.321

7.  Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization.

Authors:  M L Kripke; C G Munn; A Jeevan; J M Tang; C Bucana
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

8.  Quantitation of dendritic cells in normal and abnormal human epidermis using monoclonal antibodies directed against Ia and HTA antigens.

Authors:  R M MacKie; M L Turbitt
Journal:  J Invest Dermatol       Date:  1983-09       Impact factor: 8.551

9.  Cytochemical and ultrastructural studies of the Langerhans' cells. Sequential observations in experimental contact allergic reaction.

Authors:  B Zhao; B H Wang
Journal:  Int J Dermatol       Date:  1985-12       Impact factor: 2.736

10.  Adhesion molecules on the plasma membrane of epidermal cells. II. The intercellular adhesion molecule-1 is constitutively present on the cell surface of human resting Langerhans cells.

Authors:  G De Panfilis; G C Manara; C Ferrari; C Torresani
Journal:  J Invest Dermatol       Date:  1990-03       Impact factor: 8.551

View more
  15 in total

1.  Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection.

Authors:  M Sala; G Zambruno; J P Vartanian; A Marconi; U Bertazzoni; S Wain-Hobson
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

Review 2.  Contact dermatitis. Clinical perspectives and basic mechanisms.

Authors:  A Nasir; A A Gaspari
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

3.  IL-12 gene expression in human skin-derived CD1a+ dendritic lymph cells.

Authors:  N Yawalkar; C U Brand; L R Braathen
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

4.  GM-CSF mRNA and protein in human skin-derived lymph.

Authors:  N Yawalkar; C U Brand; L R Braathen
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

5.  Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells.

Authors:  J H de Graaf; R Y Tamminga; W A Kamps; W Timens
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

Review 6.  Antigen-presenting cell engineering. The molecular toolbox.

Authors:  M L Tykocinski; D R Kaplan; M E Medof
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

7.  Functional studies of major histocompatibility class II-positive dendritic cells and resident tissue macrophages isolated from the rat iris.

Authors:  R J Steptoe; P G Holt; P G McMenamin
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

8.  Modulation of the bovine delayed-type hypersensitivity responses to defined mycobacterial antigens by a synthetic bacterial lipopeptide.

Authors:  A O Whelan; J C Hope; C J Howard; D Clifford; R G Hewinson; H M Vordermeier
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  A mechanistic overview of dendritic cell-mediated HIV-1 trans infection: the story so far.

Authors:  Suzanne Dg Kijewski; Suryaram Gummuluru
Journal:  Future Virol       Date:  2015-03       Impact factor: 1.831

10.  Antigen-presenting cells in human cutaneous leishmaniasis due to Leishmania major.

Authors:  A M ElHassan; A Gaafar; T G Theander
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.